Andrea Paradisi

6PUBLICATIONS
47CO-AUTHORS
Molecular targetsPredictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 08, 2026
Targeting Both Oncogenic Signaling and Dependence Receptor Function is Required to Fully Suppress MET Exon 14 Skipping-Driven tumorigenesis.

|Feb 27, 2026
Prolyl 3-Hydroxylase 2 Supports a Pro-Angiogenic Milieu Promoting Colorectal Cancer Progression and Metastasis.

Sonia Panico, Antonio Adinolfi, Sara Magliacane Trotta

|Aug 26, 2023
Netrin-1 blockade inhibits tumor associated Myeloid-derived suppressor cells, cancer stemness and alleviates resistance to chemotherapy and immune checkpoint inhibitor.

Benjamin Ducarouge, Anna-Rita Redavid, Camille Victoor

|Aug 02, 2023
Netrin-1 blockade inhibits tumour growth and EMT features in endometrial cancer.

Philippe A Cassier, Raul Navaridas, Melanie Bellina

|Sep 02, 2021
Δ40p53 isoform up-regulates netrin-1/UNC5B expression and potentiates netrin-1 pro-oncogenic activity.

Yan Sun, Ambroise Manceau, Lisa Frydman

|Aug 12, 2021
A ligand-insensitive UNC5B splicing isoform regulates angiogenesis by promoting apoptosis.

Davide Pradella, Gianluca Deflorian, Alex Pezzotta

Pageof 1

Frequent Collaborators

2 joint publications

Patrick Mehlen

2 joint publications

Agnès Bernet

2 joint publications

Isabelle Ray-Coquard

2 joint publications

Nicolas Rama